Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
IS02 - Symposium by Ology Medical Education: Spotlight On Emerging Immunotherapy Approaches And MET Inhibitors In Advanced NSCLC (Not IASLC CME Accredited)
- 11:30 - 13:00
- 9/07/2019
- Location: Hilton Head (1978)
- Type: Industry Symposia & Workshops
- Track:
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-133 - Randomized Open-Label Study of Bintrafusp Alfa (M7824) vs Pembrolizumab in Patients with PD-L1 Expressing Advanced 1L NSCLC
09:45 - 09:45 | Presenter: Myung-Ju Ahn | Author(s): Fabrice Barlesi, Enriqueta Felip, Edward Garon, Claudio Martin, Tony Mok, Everett E. Vokes, Laureen S. Ojalvo, Andre Koenig, Isabelle Dussault, Luis Paz-Ares
- Abstract
Loading...
-
+
MA14 - The Adequate MTarget Is Still the Issue
- 15:45 - 17:15
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Diego Signorelli, Juergen Wolf
-
+
MA14.03 - EGFR M+ Subgroup of Phase 1b Study of Telisotuzumab Vedotin (Teliso-V) Plus Erlotinib in c-Met+ Non-Small Cell Lung Cancer
15:55 - 16:00 | Presenter: D. Ross Camidge | Author(s): Fabrice Barlesi, Jonathan Goldman, Daniel Morgensztern, Rebecca S Heist, Everett E. Vokes, Alex Spira, Eric Angevin, Wu-Chou Su, David S. Hong, John H. Strickler, Monica Motwani, Zhaowen Sun, Apurvasena Parikh, Philip Komarnitsky, Jun Wu, Karen Kelly
- Abstract
Loading...
-
+
OA12 - Profiling the Multidisciplinary Management of Stage III NSCLC
- 15:45 - 17:15
- 9/09/2019
- Location: Seoul (2007)
- IASLC CME Accredited
- Type: Oral Session
- Track: Treatment of Locoregional Disease - NSCLC
- Moderators:Dirk De Ruysscher, Bartomeu Massuti
-
+
OA12.04 - Discussant - OA12.01, OA12.02, OA12.03
16:15 - 16:25 | Presenter: Everett E. Vokes
- Abstract
No abstract available for this presentation
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-12 - Ph I Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and SBRT to Multiple Sites in Patients with Stage IV NSCLC
10:15 - 10:15 | Presenter: Jyoti D Patel | Author(s): Michael Jelinek, Christine M Bestvina, Sean Pitroda, Everett E. Vokes, Steve Chmura
- Abstract
Loading...
-
+
P2.14 - Targeted Therapy
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P2.14-12 - Tyrosine Kinase Inhibitor Resistance Mechanisms in EGFR T790M-Positive Lung Cancer: The University of Chicago Experience
10:15 - 10:15 | Presenter: Garth William Strohbehn | Author(s): Livia Szeto, Brittany Beach, Katelyn Edgington, Kirsteen Lugtu, Jeremy P Segal, Lauren Ritterhouse, Christine M Bestvina, Everett E. Vokes, Jyoti D Patel
- Abstract
Loading...
-
+
P2.18 - Treatment of Locoregional Disease - NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment of Locoregional Disease - NSCLC
-
+
P2.18-01 - A Multicenter, Double-Blind, Randomized, Controlled Study of Bintrafusp Alfa (M7824) in Unresectable Stage III NSCLC
10:15 - 10:15 | Presenter: Everett E. Vokes | Author(s): Alex A Adjei, Myung-Ju Ahn, Fabrice Barlesi, Enriqueta Felip, Edward Garon, Italia Grenga, Andre Koenig, Claudio Martin, Tony Mok, Francoise Mornex, Neru Munshi, David Raben, Clifford Robinson, Luis Paz-Ares
- Abstract
Loading...
-
+
OA14 - Update of Phase 3 Trials and the Role of HPD
- 11:30 - 13:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Julie R Brahmer, Diego Signorelli
-
+
OA14.04 - Five-Year Outcomes From the Randomized, Phase 3 Trials CheckMate 017/057: Nivolumab vs Docetaxel in Previously Treated NSCLC
12:00 - 12:10 | Presenter: Scott Gettinger | Author(s): Hossein Borghaei, Julie R Brahmer, Laura QM Chow, Marco Angelo Burgio, Javier De Castro Carpeno, Adam Pluzanski, Oscar Arrieta, Osvaldo Aren Frontera, Rita Chiari, Charles A Butts, Joanna Wojcik-Tomaszewska, Bruno Coudert, Marina Chiara Garassino, Neal Ready, Enriqueta Felip, Miriam Alonso Garcia, David M Waterhouse, Manuel Dómine, Fabrice Barlesi, Scott J. Antonia, Markus Wohlleber, David E. Gerber, Grzegorz Czyzewicz, David R Spigel, Lucio Crino, Wilfried Ernst Erich Eberhardt, Ang Li, Sathiya Marimuthu, Everett E. Vokes
- Abstract
Loading...